Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. SRI Krishna Pharmaceuticals Ltd - Unit I
FDA Inspection
•SRI Krishna Pharmaceuticals Ltd - Unit I•September 1, 2023

SRI Krishna Pharmaceuticals Ltd - Unit I – FDA Inspection, Sep 1, 2023

Record Details

This FDA Inspection record concerns SRI Krishna Pharmaceuticals Ltd - Unit I, with an inspection on September 1, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
SRI Krishna Pharmaceuticals Ltd - Unit I
Inspection Date
September 1, 2023
Product Type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Pratik S. Upadhyay (FDA Associated Person)
  • Tamil Arasu (FDA Associated Person)
View Company Profile

ID · abc43a24-1b12-4cba-9d71-bca900b6cd7d

Inspection Facts

Official Action Indicated (OAI)

Significant objectionable conditions were found and regulatory or administrative action is recommended.

Inspection number
1219348
FDA center
Human Drugs
Project area
Drug Quality Assurance
Outcome
Form 483 issued

Other FDA inspections of SRI Krishna Pharmaceuticals Ltd - Unit I

3
DateClassificationOfficeProject area
April 18, 2025Not classifiedOffice of Inspections and Investigations
May 15, 2015NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
November 17, 2011NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
Other documents for SRI Krishna Pharmaceuticals Ltd - Unit I
  • FDA Inspection 1271116 - 2025-04-18
  • FDA Inspection 928508 - 2015-05-15
  • FDA Inspection 757323 - 2011-11-17

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore SRI Krishna Pharmaceuticals Ltd - Unit I
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.